The role of fragile X mental retardation protein in major mental disorders.
about
Consensus paper: pathological role of the cerebellum in autismMolecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disordersFragile X syndrome and targeted treatment trials.Genetic Consideration of Schizotypal Traits: A ReviewMaternal genetic mutations as gestational and early life influences in producing psychiatric disease-like phenotypes in mice.Fragile X Mental Retardation Protein expression in the retina is regulated by lightEarly identification of autism in fragile X syndrome: a review.Epilepsy drives autism in neurodevelopmental disorders.Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and pubertMolecular Advances Leading to Treatment Implications for Fragile X Premutation CarriersNeuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndromeA novel assay for evaluating fragile X locus repeatsPsychosis and catatonia in fragile X: Case report and literature review.Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.Above genetics: lessons from cerebral development in autism.Imaging-genetics in autism spectrum disorder: advances, translational impact, and future directions.Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study.Dysregulation of fragile × mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain study.Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase,Defining genetically meaningful language and personality traits in relatives of individuals with fragile X syndrome and relatives of individuals with autism.Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome.Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models.2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice.DNA methylation and its basic function.Place field stability requires the metabotropic glutamate receptor, mGlu5.Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications.
P2860
Q26830626-4A2F2880-1950-4550-970D-813684A4AF38Q26853035-2E17C67D-1D61-44FD-828D-A16D7573B49AQ26865162-DFAC634A-54B5-4845-B6B0-6ACC2C6C036CQ28078642-7A2A1CD3-9AD9-4200-99F8-BD85C23643AAQ30475378-DE2360FF-332B-4615-8D08-58DC4233A9FBQ30766895-4A2C6AF1-ADCB-4206-B52E-B37EE890C9ABQ33620669-D9E8E84A-A2DD-4636-9F56-74FDB45770A0Q33733577-BA31D255-19DB-4AB1-B023-067E5644EE3BQ33926696-C18AFF1A-C79F-4E0C-9744-4364C5EDA53DQ34499370-B6689EAE-8ED4-4AD7-BA59-1A8377F3FF57Q34544358-271BDF4E-5484-4F2B-BA06-DEEEFF883B00Q34575595-BBF94AD1-F300-43DA-B875-020F073C4DCBQ34610850-85111412-27C9-466C-99BC-9B4FF86AF20EQ35356435-4D75CFD1-3593-49FF-8038-910DFBCD7DEEQ35771116-76CF0BB2-1735-46E9-85B3-B390F6A5D58DQ35802879-7FD81441-0FA9-4922-909D-742738A8CDD3Q35902641-83ECA25B-6EC9-4C2A-8E2F-A0D7907AED70Q35957857-D26FDCA0-DC43-4979-B3FC-1D8C3D39A3EFQ36132963-74B231EA-4B03-4752-99FB-8D97ED6DBCD3Q36371192-4092F90B-6A05-45B0-A8E0-7841975E0C82Q36985727-6FE39469-C7D4-4D92-AD7E-BFE25E0110A8Q37088013-D4344BAC-3454-4AA6-B14A-4F274249E584Q37372367-54620536-5235-40D0-8BDD-1B501BAB125AQ37564195-2157E61C-170C-4AB2-ACB9-E406FBD7A1E6Q37663290-46054BF9-F557-4D43-8AA7-45A5735909AFQ38025275-C08E9C70-1304-4990-8610-50A6C4941882Q43086717-B379FE91-E726-47EB-AFAC-478A5C42162BQ54375474-12B473E4-1115-4588-86EE-6765DBF62EF0
P2860
The role of fragile X mental retardation protein in major mental disorders.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The role of fragile X mental retardation protein in major mental disorders.
@ast
The role of fragile X mental retardation protein in major mental disorders.
@en
type
label
The role of fragile X mental retardation protein in major mental disorders.
@ast
The role of fragile X mental retardation protein in major mental disorders.
@en
prefLabel
The role of fragile X mental retardation protein in major mental disorders.
@ast
The role of fragile X mental retardation protein in major mental disorders.
@en
P2860
P1433
P1476
The role of fragile X mental retardation protein in major mental disorders.
@en
P2093
S Hossein Fatemi
Timothy D Folsom
P2860
P304
P356
10.1016/J.NEUROPHARM.2010.11.011
P577
2010-11-22T00:00:00Z